The median proportion of IL-6 level was higher in critical COVID-19 than sever COVID-19 patients (respectively 10.5 vs. 4.0, p < 0.05), similar tendency was for IL-8 level, but not significant (7.6 vs. 3.9, p > 0.05). Here, CXCL8 is linked to COVID-19.